Author： Liu Xiaojun Kantarjian Hagop Plunkett William
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.4, 2012-04, pp. : 541-555
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Sapacitabine receives orphan drug designation in EU.
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. :
Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. :
By Reilly R.T. Machiels J-P.H. Jaffee E.M.
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 2, 2000-07 ,pp. :